@ranjitbindra
Harvey & Kate Cushing Professor at Yale; Co-Director, Yale Brain Tumor Center; CNS RadOnc; Biotech Entrepreneur; Surprisingly good drummer…
The Sontag Foundation @sontagfdnThe @SontagFund marks a major #braincancer milestone: @YaleMed research by Dr. @ranjitbindra led to @modifibio. In 2024, @Merck acquired Modifi Bio to continue development of this promising molecule. Read more:
Yale Cancer Center @YaleCancer~25–30% of #AML has MGMT silencing—a targetable vulnerability. New research presented by @Prateek_Bhardwj identifies KL50, a novel crosslinking compound, as highly potent in MGMT-silenced AML. The data shared #ASH25 strongly supports MGMT-guided clinical trials of KL50. @Halene_lab @ranjitbindra @YaleHematology @ASH_hematology
Yale Radiation Oncology Residency @YaleRadOncYale Therapeutic Radiology has made it to #ASTRO25! Excited to learn, collaborate, and showcase our own work in the great city of San Francisco! 🌁
Juan Vasquez, MD @JcvasqVHonored to receive this award! Grateful to @YalePediatrics @YaleCancer @SmilowCancer and to past and current mentors, particularly @ranjitbindra for their support. Excited to move forward in developing new therapies for children with cancer!
Yale Cancer Center @YaleCancerJames Elia @yalepathology has been awarded a prestigious Ruth L. Kirschstein Predoctoral Individual National Research Service Award #F31 from @NIH for his project, “Exploiting Homologous Recombination Defects with a Novel DNA-Crosslinking Strategy.” @SmilowCancer @ranjitbindra
Yale Cancer Center @YaleCancerJames Elia @yalepathology has been awarded a prestigious Ruth L. Kirschstein Predoctoral Individual National Research Service Award #F31 from @NIH for his project, “Exploiting Homologous Recombination Defects with a Novel DNA-Crosslinking Strategy.” @SmilowCancer @ranjitbindra
Henry S. Park, MD, MPH @HenryParkMDGrateful to be promoted to full professor @YaleMed! I truly appreciate all the support along the way, including from countless mentors, colleagues, letter writers, trainees, friends, and family, especially my parents and wife. I plan to pay it forward! @YaleCancer @YaleRadOnc
Angela Kim @AngKim99Had an amazing time at @YaleCancer 8th annual symposium! I had the honor of presenting our work on NAPRT-loss in pediatric rhabdomyosarcoma. All thanks to my amazing mentors, @JcvasqV and @ranjitbindra, as well as all the collaborators 🙌 @Shahyan_Rehman @yalepathology
Yale Cancer Center @YaleCancerNew research led by James Elia #BindraLab @ranjitbindra, led to development of a pioneering, free software application #CellPyAbility, a tool to simplify + enhance analysis of cell viability data. @SmilowCancer @YaleMed @YNHH #NCRM25 #unitedbycancerresearch @AACR
Juan Vasquez, MD @JcvasqVWonderful talk by @AngKim99 on loss of NAPRT expression in rhabdomyosarcoma and implications for therapeutic targeting of NAD! @YalePediatrics @YaleCancer @yalepathology @ranjitbindra
